Luveltamab Tazevibulin

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 23:37:09 GMT 2025` Edited by `admin` on `Tue Apr 01 23:37:09 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG1
Sequence Type	COMPLETE
Record UNII	XDE2GOF1JT
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Immunoglobulin G1 [188,412-bis[4-(azidomethyl)-L-phenylalanine]], anti-(human folate receptor ?) (human-Mus musculus monoclonal SP8166 ?1-chain), disulfide with human-Mus musculus monoclonal SP8166 ?-chain, dimer, click reaction product with 3-[[[[4-[[N-

Preferred Name

English

Luveltamab Tazevibulin

Official Name

English

SP-8193

Code

English

STRO-002

Code

English

Luveltamab tazevibulin [WHO-DD]

Common Name

English

luveltamab tazevibulin [INN]

Common Name

English

LUVELTAMAB TAZEVIBULIN [USAN]

Common Name

English

SP8193

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

915722

Created by admin on Tue Apr 01 23:37:09 GMT 2025 , Edited by admin on Tue Apr 01 23:37:09 GMT 2025

Code System Code Type Description

INN

12040

Created by admin on Tue Apr 01 23:37:09 GMT 2025 , Edited by admin on Tue Apr 01 23:37:09 GMT 2025

PRIMARY

USAN

LM-107

Created by admin on Tue Apr 01 23:37:09 GMT 2025 , Edited by admin on Tue Apr 01 23:37:09 GMT 2025

PRIMARY

SMS_ID

300000017513

Created by admin on Tue Apr 01 23:37:09 GMT 2025 , Edited by admin on Tue Apr 01 23:37:09 GMT 2025

PRIMARY

NCI_THESAURUS

C158067

Created by admin on Tue Apr 01 23:37:09 GMT 2025 , Edited by admin on Tue Apr 01 23:37:09 GMT 2025

PRIMARY

CAS

2493327-62-9

Created by admin on Tue Apr 01 23:37:09 GMT 2025 , Edited by admin on Tue Apr 01 23:37:09 GMT 2025

PRIMARY

FDA UNII

XDE2GOF1JT

Created by admin on Tue Apr 01 23:37:09 GMT 2025 , Edited by admin on Tue Apr 01 23:37:09 GMT 2025

PRIMARY

From	To
1_23	1_97
1_152	1_208
1_228	3_215
1_234	2_234
1_237	2_237
1_269	1_329
1_375	1_433
2_23	2_97
2_152	2_208
2_228	4_215
2_269	2_329
2_375	2_433
3_24	3_89
3_135	3_195
4_24	4_89
4_135	4_195

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
DRUG LINKER	[1_188] [1_412] [2_188] [2_412]	SITE_SPECIFIC			LUVELTAMAB TAZEVIBULIN L-PHENYLALANINE DRUG LINKER	H9TI1AHL8M

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL